EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Shaping Clinical Policy for Salvage Radiotherapy After Radical Prostatectomy in Prostate Cancer: Bridging the Gap Between Clinical Trials and Daily Practice

Piero Bettoli iD, Evangelina Röling, Moises Russo, María Fernanda Sánchez, Inti Paredes, Jorge Sapunar

Cancer Medicine · 2024

DOI: 10.1002/cam4.70362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Piero Bettoli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Arturo López Pérez Foundation Cancer Centre, Santiago, Chile. Hauptthemen laut MEDLINE: Prostatectomy, Prostatic Neoplasms, Salvage Therapy, Prostate-Specific Antigen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose and Objective Salvage radiotherapy (sRT) can have similar outcomes to adjuvant radiotherapy (aRT) if administered at the earliest evidence of biochemical recurrence. RADICALS‐RT was the first trial to support this hypothesis and a policy of observation after radical prostatectomy (RP) with early sRT has become the new standard of care since then. This study assessed the impact of RADICALS‐RT in the clinical practice regarding the timing of sRT for prostate cancer initially treated with RP.

Methods

Data from 297 patients who underwent sRT after radical RP were retrospectively collected. Two groups were created and analyzed on the basis of the date of RADICALS‐RT presentation at ESMO. After these results were released in October 2021, our institutional postoperative radiotherapy policy was revisited, and a third group was created and analyzed separately.

Results

Median PSA for Groups 1, 2, and 3 were 0.33, 0.27, and 0.2, respectively. Less than one‐third of patients in Groups 1 and 2 had a postoperative PSA of 0.2 ng/mL or less at the time of sRT. Group 3 showed statistically significant differences in median PSA at the time of sRT compared with Groups 1 and 2.

Conclusions

RADICALS‐RT demonstrated a significant impact on clinical practice only after being complemented with real local evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatectomyProstatic NeoplasmsSalvage TherapyProstate-Specific AntigenHumansMaleMiddle AgedAgedRetrospective StudiesRadiotherapy, AdjuvantNeoplasm Recurrence, LocalClinical Trials as Topic

Stichwörter der Autor:innen

clinical trialsprostate cancerradiotherapysurgery

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Radiation Oncology, Arturo López Pérez Foundation Cancer Centre, Santiago, Chile.
  • Department of Cancer Research, Arturo López Pérez Foundation Cancer Centre, Santiago, Chile.
  • Department of Digital Health and Medical Informatics, Arturo López Pérez Foundation Cancer Centre, Santiago, Chile.

ORCID-Profile: Piero Bettoli

Zitieren

APA

Bettoli, P., Röling, E., Russo, M., Sánchez, M. F., Paredes, I., & Sapunar, J. (2024). Shaping Clinical Policy for Salvage Radiotherapy After Radical Prostatectomy in Prostate Cancer: Bridging the Gap Between Clinical Trials and Daily Practice. Cancer Medicine. https://doi.org/10.1002/cam4.70362

Vancouver

Bettoli P, Röling E, Russo M, Sánchez MF, Paredes I, Sapunar J. Shaping Clinical Policy for Salvage Radiotherapy After Radical Prostatectomy in Prostate Cancer: Bridging the Gap Between Clinical Trials and Daily Practice. Cancer Medicine. 2024. doi:10.1002/cam4.70362

BibTeX
@article{Bettoli2024,
  author = {Bettoli, Piero and Röling, Evangelina and Russo, Moises and Sánchez, María Fernanda and Paredes, Inti and Sapunar, Jorge},
  title = {Shaping Clinical Policy for Salvage Radiotherapy After Radical Prostatectomy in Prostate Cancer: Bridging the Gap Between Clinical Trials and Daily Practice},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70362}
}
Kostenlos starten →